KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Capital Leases (2019 - 2025)

Opko Health (OPK) has disclosed Capital Leases for 5 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Leases fell 16.49% year-over-year to $3.4 million, compared with a TTM value of $3.4 million through Dec 2025, down 16.49%, and an annual FY2025 reading of $3.4 million, down 16.49% over the prior year.
  • Capital Leases was $3.4 million for Q4 2025 at Opko Health, up from $3.4 million in the prior quarter.
  • Across five years, Capital Leases topped out at $7.7 million in Q3 2023 and bottomed at $3.4 million in Q3 2025.
  • Average Capital Leases over 4 years is $5.1 million, with a median of $4.6 million recorded in 2024.
  • The sharpest move saw Capital Leases rose 2.61% in 2023, then tumbled 44.13% in 2024.
  • Year by year, Capital Leases stood at $7.1 million in 2022, then grew by 2.61% to $7.3 million in 2023, then tumbled by 44.13% to $4.1 million in 2024, then decreased by 16.49% to $3.4 million in 2025.
  • Business Quant data shows Capital Leases for OPK at $3.4 million in Q4 2025, $3.4 million in Q3 2025, and $3.7 million in Q2 2025.